ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 3: Percutaneous coronary interventions: technique and new devices
Mon 29 Aug 08:30 - 12:30 PCI / stents: devices and technique Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:30P2396Transradial versus transulnar artery coronary interventions: a randomized studyGeogios CHACHALIS (Patras, GR)
08:30P2397Longterm clinical and angiographic outcome after stent-implantation versus off-pump coronary bypass surgeryHendrik NATHOE (Soest, NL)
08:30P2398Arstasis ITG device, an arterial closure device without inserting foreign material: first multicenter experience in more than 1000 patientsThilo TUBLER (Hamburg, DE)
08:30P2399Coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13 months: an optical coherence tomography substudy from the RESOLUTE AC trialJuan Luis GUTIERREZ-CHICO (Munich, DE)
08:30P2400An international collaborative meta-analysis on the incidence of coronary stent thrombosis including 30 studies, 225,536 patients, and 4,203 thrombosesGiuseppe SANGIORGI (Modena, IT)
08:30P2401Applying the national institute for clinical excellence criteria to patients treated with the EPC capturing stent: a sub-study of the e-HEALING registryMargo KLOMP (Amsterdam, NL)
08:30P2402Practice of treatment of in-stent-stenosis in PCI for ACS in clinical practice in europe: results of the EHS PCI registryAnselm Kai GITT (Ludwigshafen, DE)
08:30P2403Safety of retrograde recanalizations to chronic total occlusion via transseptal pathways with use of a novel metal-catheter analyzed by echocardiographyHideyuki TAKIMURA (Kanagawa, JP)
08:30P2404Paclitaxel versus sirolimus eluting stents in diabetic patients: does stent type and/or stent diameter matter? Michela FACCHIN (Padova, IT)
08:30P2405Clinical experience with second generation PES vs EES in US contemporary practice (rewards TLX trial)Ron WAKSMAN (Washington, US)
08:30P2406Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo-assessment with optical coherence tomographyJuan Luis GUTIERREZ-CHICO (Munich, DE)
08:30P2407Same wrist intervention via the cubital (ulnar) artery in case of radial puncture failure for percutaneous cardiac catheterization or intervention: the multicenter prospective SWITCH registryPierfrancesco AGOSTONI (Utrecht, NL)
08:30P2408Percutaneous coronary intervention using radial access is associated with less radiation exposure to patients compared with femoral accessVijayalakshmi KUNADIAN (Newcastle Upon Tyne, GB)
08:30P2409Comparison of zotarolimus- and everolimus-eluting coronary stents in patients with a single vessel diseaseKonstantinos TOUTOUZAS (Athens, GR)
08:30P2410No recovery of drug-eluting stent use in clinical practice in europe after the collaps following the initial reports of impaired outcomes in september 2006: results of the euro heart PCI-registryAnselm Kai GITT (Ludwigshafen, DE)
08:30P2411Stent recoil varies with drug eluting stent design and influences long-term luminal loss: results of a longitudinal study including four different stent platformsTo Be Announced
08:30P2412Four-year safety and efficacy of sirolimus- and paclitaxel-eluting stents in patient with acute myocardial infarctionJin-Ok JEONG (Daejeon, KR)
08:30P2413Acute stent recoil is increased in cobalt chromium compared to stainless steel stents.Darren MYLOTTE (Massy, FR)
08:30P2414Impact of the everolimus eluting stent on stent thrombosis: a meta-analysis Usman BABER (New York City, US)
08:30P2415Clinical outcomes of biodegradable-polymer drug eluting stents , a meta-analysis and systematic review of randomized and observational studies.Tarek AHMED (Leiden, NL)